- Home
- MRVI vs CLPT Comparison
MRVI vs CLPT Comparison
Compare MRVI & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRVI | CLPT |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 435.7M |
| IPO Year | 2020 | 2009 |
Fundamental Metrics
Financial Performance| Metric | MRVI | CLPT |
|---|---|---|
| Price | $5.80 | $15.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $4.13 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 2.2M | 612.6K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $185,743,000.00 | $36,971,000.00 |
| Revenue This Year | $12.54 | $45.67 |
| Revenue Next Year | $7.87 | $19.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $2.29 | $8.27 |
| 52 Week High | $7.44 | $30.10 |
Technical Indicators
Market Signals| Indicator | MRVI | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 36.84 | 54.02 |
| Support Level | $5.67 | $12.77 |
| Resistance Level | $6.55 | $16.54 |
| Average True Range (ATR) | 0.34 | 0.69 |
| MACD | -0.15 | 0.14 |
| Stochastic Oscillator | 24.84 | 96.93 |
Price Performance
Historical ComparisonAbout MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.